The financing consists of two separate tranches and has been raised from the European Investment Bank (EIB). The financing is structured as venture debt, a flexible form of financing aimed at supporting the company’s growth. The loan of EUR 22.5 million will support Chromafora’s development of the SELPAXT technology for PFAS treatment and deployment of water-treatment units at sites across Europe between 2024 and 2028.
“The EIB loan is a fantastic verification of our technology, as well as an enabler for faster expansion in Europe. There is a high demand for treating wastewater from PFAS” said Chromafora CEO Johan Seijmer.
For more information from EIB, read more on this link.
We are happy to tell you more about the loan from EIB, similar financing opportunities, how we work and what we can offer our customers!
Neptune Partners offers financial and legal advice in financing and business transactions, where we, as an independent actor, can offer our clients a palette of options that includes all types of debt financing; via banks, financial institutions, debt funds, and family offices.
